United Spirits (UNSP) wrapped up Q4FY25 on a steady note. Backed by robust value and volume growth, strategic tailwinds, and regulatory support, the company is setting the stage for sustained earnings expansion—even as it faces a few near-term consumption challenges.
Here’s how the numbers shaped up this quarter:
These numbers are a testament to the brand’s resilience and continued consumer demand.
The company is upbeat on growth, forecasting:
This optimism is supported by the recent UK Free Trade Agreement (FTA) and product mix optimization that’s expected to bolster margins and profitability further.
While Q4 showed solid topline growth, management did caution about broad-based consumption weakness in the near term. Competitive intensity and potential shifts in discretionary spending could moderate some of the demand tailwinds over the next few quarters.
Metric | Q4FY25 Highlights |
---|---|
Net Revenue | ₹2,918.4 crore (+10.5% YoY) |
Volume | 16.7 million cases (+7% YoY) |
EBITDA | ₹505 crore (+39.5% YoY, 10.4% beat) |
FY26E Earnings | +12.1% growth expected |
FY27E Earnings | +18.8% growth expected |
P/E (FY27E EPS) | 60.9x |
Revised FV | ₹1,575 (earlier ₹1,480) |
The stock is currently trading at a P/E of 60.9x FY27E EPS, reflecting investor confidence in the company’s brand and operational strength. With the fair value revised to ₹1,575, the company’s focus on product innovation, channel expansion, and margin improvement keeps it in a solid “ADD” zone.
United Spirits’ Q4FY25 was marked by steady volume growth, resilient profitability, and encouraging policy tailwinds. While near-term consumption headwinds are on the radar, the company’s roadmap and execution capability remain strong—cheers to that!
This feature is based on a synopsis of a research report issued by Kotak Securities Limited. For the full story (and disclaimers), make sure to check out the original sources:
Investments in securities market are subject to market risks, read all the related documents carefully before investing. This information is purely backed by KSL research analyst based on research recommendation. Kotak Securities Ltd has registration granted by SEBI, Enlistment as RA and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400051. SEBI Registration No. INZ000200137 (Member of NSE, BSE, MSE, MCX & NCDEX), Member Id: NSE-08081; BSE-673; MSE-1024; MCX-56285; NCDEX-1262. Research Analyst INH000000586; BSE Enlistment No: 5035 for compliance T&C and disclaimers, Visit https://ddei5-0-ctp.trendmicro.com:443/wis/clicktime/v1/query?url=https%3a%2f%2fbit.ly%2flongdisc&umid=818E14E7-34FE-7906-906B-8F0B1C42A394&auth=d2c41a7df2e2ef1fca42bbbefb1c825d24cf1548-36f3d1caa4f5ef82b030dac05eca909befcec775,